Get the app!
Back to Trades
Buy4

Rapport Therapeutics, Inc.

RAPP

Total Value
$1.0M
Net $1.0M bought
Purchases
$1.0M
2 transactions

Company Information

Ticker Symbol
RAPP
CIK
0002012593

Insider Information

Role
Insider
Location
BOSTON, MA

Filing Details

Filing Date
Sep 15, 2025
Transaction Date
Sep 12, 2025
Accession Number
0001193125-25-203537
Form Type
4
Net Trading Amount
$1.0M

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Sep 12, 2025Common Stock28,284$24.50Purchase$692.9K
Sep 12, 2025Common Stock13,382$24.97Purchase$334.2K

Footnotes

  1. (F1)The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $23.90 to $24.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
  2. (F2)Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
  3. (F3)The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.90 to $25.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.